Jaguahr Therapeutics Overview
- Year Founded
-
2019
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
2
Jaguahr Therapeutics General Information
Description
Developer of immuno-oncology therapeutics intended to deliver clinical candidate drugs. The company offers novel immuno-oncology therapeutics targeting the aryl hydrocarbon receptor pathway, thereby enabling clients to avail of oncology-focused therapies and drugs.
Contact Information
Website
www.jaguahr.com(Operating Subsidiary)
Corporate Office
- 5 Shenton Way
- Suite 10-01, UIC Building
- Singapore, 039190
- Singapore
Corporate Office
- 5 Shenton Way
- Suite 10-01, UIC Building
- Singapore, 039190
- Singapore
Jaguahr Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Jaguahr Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Jaguahr Therapeutics Patents
Jaguahr Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4598931-A1 | Compounds useful in modulation of ahr signalling | Pending | 03-Oct-2022 | ||
| US-20260347371-A1 | Compounds useful in modulation of ahr signalling | Pending | 03-Oct-2022 | ||
| WO-2024076300-A1 | Compounds useful in modulation of ahr signalling | Inactive | 03-Oct-2022 | ||
| EP-4396191-A1 | Compounds useful in modulation of ahr signalling | Active | 02-Sep-2021 | ||
| EP-4396191-B1 | Compounds useful in modulation of ahr signalling | Active | 02-Sep-2021 | C07D498/04 |
Jaguahr Therapeutics FAQs
-
When was Jaguahr Therapeutics founded?
Jaguahr Therapeutics was founded in 2019.
-
Where is Jaguahr Therapeutics headquartered?
Jaguahr Therapeutics is headquartered in Singapore, Singapore.
-
What industry is Jaguahr Therapeutics in?
Jaguahr Therapeutics’s primary industry is Drug Discovery.
-
Is Jaguahr Therapeutics a private or public company?
Jaguahr Therapeutics is a Private company.
-
What is the current valuation of Jaguahr Therapeutics?
The current valuation of Jaguahr Therapeutics is .
-
What is Jaguahr Therapeutics’s current revenue?
The current revenue for Jaguahr Therapeutics is .
-
When was Jaguahr Therapeutics acquired?
Jaguahr Therapeutics was acquired on 28-Apr-2021.
-
Who acquired Jaguahr Therapeutics?
Jaguahr Therapeutics was acquired by Bukwang Pharmaceutical.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
